A 43-kDa circulating filarial antigen fraction of Wuchereria bancrofti in immunoprophylaxis against Brugia malayi in jirds-Reference-Cited by-同舟云学术

A 43-kDa circulating filarial antigen fraction of Wuchereria bancrofti in immunoprophylaxis against Brugia malayi in jirds

Published:2000-02 Issue:4 Volume:48 Page:281-288
ISSN:1383-5769
Container-title:Parasitology International
language:en
Short-container-title:Parasitology International

Author:

Vasu Chenthamarakshan,Venkatarami Reddy Maryata,Chinnaiah Harinath Baskar

Publisher

Elsevier BV

Subject

Infectious Diseases,Parasitology

Reference28 articles.

1. Immunity in filariasis: perspective for vaccine development;Philipp;Annu Rev Microbiol,1988

2. World Health Organization. Protective immunity and vaccination in onchocerciasis and lymphatic filariasis. Report of the thirteenth meeting of the scientific working group of filariasis. Geneva: WHO document TDR/FIL/SWG (13)/87.3, 1987.

3. Immunological tolerance: the key feature in human filariasis?;Maizels;Parasitol Today,1991

4. Differential reactivity of filarial antigens with human sera from bancroftian filariasis endemic zone;Cheirmaraj;J Biosci,1991

5. Protective immunity in bancroftian filariasis. Selective recognition of a 42 kDa larval stage antigen by infection free individual in an endemic area;Freedman;J Clin Invest,1989

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive, Model-Based Review of Vaccine and Repeat Infection Trials for Filariasis;Clinical Microbiology Reviews;2013-07

2. Prophylactic evaluation of recombinant extracellular superoxide dismutase of Brugia malayi in jird model;Vaccine;2008-07

3. Vaccination with Setaria cervi 175kDa collagenase induces high level of protection against Brugia malayi infection in jirds;Vaccine;2006-09

4. Immunoprophylactic evaluation of a 37-kDa Brugia malayi recombinant antigen in lymphatic filariasis;Clinical Microbiology and Infection;2006-04

5. Lymphatic filariasis: new insights and prospects for control;Current Opinion in Infectious Diseases;2001-10